Dosing guidelines, not protocols, for managing warfarin therapy

American Journal of Health-System Pharmacy

Volumn 67, Issue 18, 2010, Pages 1554-1556

  Wittkowsky, Ann K ^a,b   Spinler, Sara H A ^c   Dager, William ^d   Gulseth, Michael P ^e   Nutescu, Edith A ^f,g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTH DAKOTA   (United States)

^f Department of Pharmacy Practice   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; DRUG DOSE REGIMEN; HUMAN; NOMOGRAM; NOTE; PARTIAL THROMBOPLASTIN TIME; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; CLINICAL PRACTICE; DOSE CALCULATION; DOSE RESPONSE; HOSPITAL; UNITED STATES;

ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; HOSPITALS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; WARFARIN;

EID: 79952112898     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100064     Document Type: Note

References (22)

1. Joint Commission. National Patient Safety Goals, 2010. www.jointcommission.org/NR/rdonlyres/868C9E07-037F-433D-8858-0D5FAA4322F2/0/ RevisedChapter-HAP-NPSG-20090924.pdf (accessed 2010 Jan 28).
2. Rich DS. Pharmacies' noncompliance with 2009 Joint Commission hospital accreditation requirements. Am J Health-Syst Pharm. 2010; 67:144-7.
3. Dobesh PP. Unfractionated heparin dosing nomograms: roadmaps to where? Pharmacotherapy. 2004; 24:142s-145s.
4. Kovacs MJ, Anderson DA, Wells PS. Prospective assessment of a nomogram for the initiation of oral anticoagulant therapy for outpatient treatment of venous thromboembolism. Pathophysiol Haemost Thromb. 2002; 32:131-3. (Pubitemid 37490503)
5. Oates A, Jackson PR, Austin CA et al. A new regimen for starting warfarin therapy in outpatients. Br J Clin Pharmacol. 1998; 46:157-61. (Pubitemid 28342787)
6. Pengo V, Biasiolo A, Pegoraro C. A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation. Am J Cardiol. 2001; 88:1214-6. (Pubitemid 33043866)
7. Siguret V, Gouin I, Debray M et al. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen. Am J Med. 2005; 118:137-42. (Pubitemid 40202860)
8. Tait RC, Sefcick A. A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation. Br J Haematol. 1998; 101:450-4. (Pubitemid 28266936)
9. Lazo-Langer A, Monkman K, Kovacs J. Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram. J Thromb Haemost. 2009; 7:1276-83.
10. Cosh DG, Moritz CK, Ashman KJ et al. Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose. Aust N Z J Med. 1989; 19:191-7. (Pubitemid 19230316)
11. Fennerty A, Dolben J, Thomas J et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br J Med. 1984; 288:1268-70. (Pubitemid 14117132)
12. Gedge J, Orme S, Hampton KK et al. A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing. 2000; 29:31-4. (Pubitemid 30055060)
13. Roberts GW, Druskeit T, Jorgensel LE et al. Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol. Aust N Z J Med. 1999; 29:731-6. (Pubitemid 29530192)
14. Roberts GW, Helboe T, Nielsen CB et al. Assessment of an age-adjusted warfarin initiation protocol. Ann Pharmacother. 2003; 37:799-803. (Pubitemid 36618363)
15. Crowther MA, Ginsberg JB, Kearon C et al. A randomized trial comparing 5mg and 10mg warfarin loading doses. Arch Intern Med. 1999; 159:46-8. (Pubitemid 29044118)
16. Crowther MA, Harrison L, Hirsh J. Warfarin: less may be better. Ann Intern Med. 1997; 127:332-3.
17. Gage BF, Fihn SD, White RH. Management and dosing of warfarin therapy. Am J Med. 2000; 109:481-8.
18. Wittkowsky AK. Warfarin. In: Murphy JE, ed. Clinical pharmacokinetics. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2008.
19. Garcia DA, Witt DM, Hylek E et al. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother. 2008; 42:979-88.
20. Dager WE, Gulseth MP. Implementing anticoagulation management by pharmacists in the inpatient setting. Am J Health-Syst Pharm. 2007; 64:1071-9. (Pubitemid 46801539)
21. Witt DM, Sadler MA, Shanahan RL et al. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005; 127:1515-22. (Pubitemid 46218774)
22. Ansell J, Hirsh J, Hyleck E et al. Pharmacology and management of the vitamin K antagonists. Chest. 2008; 133(suppl):160S-198S.